Literature DB >> 25410715

Evolving role of positron emission tomography (PET) in urological malignancy.

Sebastian Mafeld1, Nikhil Vasdev2,3, Amit Patel3, Tamir Ali1, Timothy Lane3, Gregory Boustead3, Andrew C Thorpe2, James M Adshead3, Philip Haslam1.   

Abstract

We present a review on the increasing indications for the use of positron emission tomography (PET) in uro-oncology. In this review we describe the details of the different types of PET scans, indications for requesting PET scans in specific urological malignancy and the interpretation of the results.
© 2014 The Authors BJU International © 2014 BJU International Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  indication; positron emission tomography (PET); urological malignancy

Mesh：

Substances：

Year:  2015        PMID： 25410715     DOI： 10.1111/bju.12988

Source DB:  PubMed          Journal:  BJU Int        ISSN： 1464-4096            Impact factor:   5.588


  3 in total

1.  Delayed post-diuretic 18F-FDG PET/CT for preoperative evaluation of renal pelvic cancer.

Authors:  Yiping Shi; Ruohua Chen; Yining Wang; Gan Huang; Qian Xia; Jianjun Liu
Journal:  J Cancer       Date:  2020-04-06       Impact factor: 4.207

2.  Early differences in dynamic uptake of 68Ga-PSMA-11 in primary prostate cancer: A test-retest study.

Authors:  J Olde Heuvel; B J de Wit-van der Veen; M Sinaasappel; C H Slump; M P M Stokkel
Journal:  PLoS One       Date:  2021-02-02       Impact factor: 3.240

3.  Delayed 18F-FDG PET/CT Appearance of Urachal Adenocarcinomas.

Authors:  Lian Xu; Yiping Shi; Yining Wang; Xiang Zhou; Gan Huang; Ruohua Chen; Jianjun Liu
Journal:  Contrast Media Mol Imaging       Date:  2020-09-14       Impact factor: 3.161
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.